retatrutide triple agonist gip glp-1 glucagon receptor 40mg Retatrutide vs Tirzepatide 🔬 What's

Introduction Significant reductions in cardiovascular events, all-cause mortality, and the advancement of kidney disease are demonstrated by important studies such as FLOW

Medicare has never paid for weight-loss drugs at scale

GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health

The diabetes indication segment accounted for the largest share of the market

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Learn about the Ozempic blindness lawsuit, including NAION and other vision problems, and read about the study linking semaglutide use to severe eye problems.